Conquering Diseases

Study Of An Investigational Drug For Covid-19 In Children At Risk Of Severe Disease

Description

Seeking children younger than 18 who have COVID-19 and are at risk for serious disease but have not been hospitalized for a study of an investigational drug.

Overview

Participants in this study will take a pill twice a day for 5 days. There will be a total of 8 study visits, some of which may be done from home.

What we're hoping for

We are studying whether an investigational drug taken by mouth at home is safe and effective in preventing serious disease from COVID-19 in children aged 0-17 who are at risk for serious disease.

Additional Information

ClinicalTrials.gov Identifier: NCT05261139

 Principal Investigator

Katherine  Luzuriaga, MD

University of Massachusetts Medical School

 Study Contact

The Clinical Research  Center

508-856-2800

clinicaltrialsunit@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989